Case report of patients with acute respiratory distress syndrome caused by covid-19: Successfully treated by venovenous extracorporeal membrane oxygenation and an ultra-protective ventilation

1Citations
Citations of this article
94Readers
Mendeley users who have this article in their library.

Abstract

Coronavirus disease (COVID-19) started in Wuhan (China) at the end of 2019, and then increased rapidly. In patients with severe acute respiratory distress syndrome (ARDS) caused by COVID-19, venovenous extracorporeal membrane oxygenation (VV-ECMO) is considered a rescue therapy that provides adequate gas exchange. The way in which mechanical ventilation is applied during VV-ECMO is not clear, however it is associated with prognosis. Currently, the mortality rate of COVID-19 patients that receive VV-ECMO stands at approximately 50%. Here, we report three patients that successfully recovered from COVID-19-induced ARDS after VV-ECMO and implementation of an ultra-protective ventilation. This ventilation strategy involved maintaining a peak inspiratory pressure of ≤20 cmH2 O and a positive end-expiratory pressure (PEEP) of ≤10 cmH2 O, which are lower values than have been previously reported. Thus, we suggest that this ultra-protective ventilation be considered during VV-ECMO as it minimizes the ventilator-induced lung injury.

Cite

CITATION STYLE

APA

Park, M. H., Kim, A. J., Lee, M. J., Kim, Y. S., & Kim, J. S. (2020). Case report of patients with acute respiratory distress syndrome caused by covid-19: Successfully treated by venovenous extracorporeal membrane oxygenation and an ultra-protective ventilation. Medicina (Lithuania), 56(11), 1–8. https://doi.org/10.3390/medicina56110570

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free